Accel Research Site - Achieve - Birmingham

Birmingham, Alabama 35216

0 studies enrolling now · 2 studies all time

What they study most

Influenza, Respiratory Syncytial Virus, SARS-CoV-2

Studies at this site

• A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age — Completed
• A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age — Completed